COVID-19 Resources > COVID-19 Web Series FAQs

2020_COVID_Page_Banners/COVID FAQ Banner

Chloroquine and Hydroxychloroquine

These FAQs were developed from the webinar "Use and Potential Adverse Effects of Chloroquine & Hydroxychloroquine for COVID-19" held on March 25, 2020. 

Clinical Concerns in Emergency Departments and Opioid Treatment Centers

These FAQs were developed from the webinar "Poison Centers & COVID-19" held on April 15, 2020. 

FDA EUA and Literature Update

These FAQs were developed from the webinar "FDA Regulatory Toolbox" held on April 22, 2020. 

Influenza Testing

These FAQs were developed from the webinar "Testing and Treatment of 2020-2021 Seasonal Influenza During the COVID-19 Pandemic" held on November 20, 2020. 

NSAIDs, ACEI, ARBs, and Remdesivir

These FAQs were developed from the webinar "ACEs/ARBs, NSAIDS, Remdesivir" held on April 1, 2020. 

Personal Protective Equipment (PPE)

These FAQs were developed from the webinars "Masks and COVID19: N95, PAPRs, Surgical Masks and Scarves" held on April 8, 2020 and "PPE Town Hall Q&A" held on April 24, 2020.

Poison Center COVID-19 Related Surveillance

These FAQs were developed from the webinar "Poison Centers & COVID-19" held on April 15, 2020. 

Psychological Resiliency

These FAQs were developed from the webinar "Psychological Resilience During COVID-19 and Beyond" held on May 13, 2020. 

Testing

These FAQs were developed from the following webinars: "SARS-CoV-2 Testing" (held on April 29, 2020), "Antibodies" (held on July 22, 2020 and "Saliva Testing" (held on September 30, 2020).

Vaccine

These FAQs were developed from the following webinars: "Vaccine Strategy" (held on July 8, 2020), "Vaccine Safety" (held on September 16, 2020), "Vaccine Update" (held on October 28, 2020) and "Vaccine Implementation" (held on January 6, 2021).